Clinical trial
Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical Cancer
NCT01851772 is registered in ClinicalTrials.gov with Xoft, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical Cancer
- Lead sponsor
- Xoft, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 30, 2013
- Completion date
- June 30, 2015
- Enrollment
- 3 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cervical cancer